Material Type

• Dried whole blood (2)
• Isolated peripheral blood mononuclear cells (non viable) (2)
• Other (1)
• Pathogen DNA (Derivative) (1)
• Plasma (single spun) (2)
• Serum (4)
• Stool (3)
• Swab medium (1)
• Urine (random) (2)

Microscopic Assessment

• Affected (2)
• Non-affected (1)
• Not applicable (5)

Storage Temperature

• -35°C to -18°C (3)
• -85°C to -60°C (5)

Associated Data

• Biomarker datasets (1)
• Clinical records (3)
• Followup records (3)
• Freezer temperature logs (4)
• Genomic datasets (2)
• Imaging data (2)
• Microbiological results (2)
• Participant Ethnicity (2)
• Physiological/biochemical measurements (1)
• Survey data (7)
• Treatment records (3)

Timeframe

• Immediate (2)
• 0 - 3 months (6)
• 3 - 6 months (1)
• > 6 months (2)

Participant Count

• 1 - 10 (1)
• 11 - 100 (4)
• 101 - 500 (3)

Sex

• Both sexes (7)

Age Range

• Young adult (18 - 40 years) (7)

Biobank Services

• Ability to recontact (1)
• Cell culture (1)
• Infectious strain isolation (2)
• Molecular Extractions (2)
• Nucleic acid extraction (3)

Collection Type

• Case-control (1)
• Cohort (1)
• Cross-sectional (3)
• Disease specific (2)

Consent Restriction

• No Commercial restriction (4)
• No Disease area restriction (7)
• No Export restriction (7)
• No Genetic analysis restriction (4)
• No Human genetic analysis restriction (3)
• No restrictions (2)
• No Project specific restriction (6)
• No Scope of use restriction (7)

Collection Status

• Completed (2)
• In progress (5)
• Not-started (1)

Access Condition

• Open to applicants (2)
• Open only through collaboration (4)
• Access restricted at present (1)

Country

• Belgium (1)
• Cameroon (1)
• Ghana (1)
• India (1)
• Peru (2)
• Philippines (1)
• United States (1)

County